Alpha Tau Medical Ltd. Company Profile
NASDAQ: DRTSHealth CareMedical/Dental InstrumentsUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Alpha Tau Medical at a glance
Alpha Tau Medical Ltd. (NASDAQ: DRTS) is a Medical/Dental Instruments company in the Health Care sector headquartered in Jerusalem, Israel. Alpha Tau Medical is led by Mr. Uzi Sofer and employs about 121 people. At a market capitalization of $1.09 billion, it is considered a small-cap company.
Its SEC Central Index Key (CIK) is 0001871321, which identifies the company's filings on EDGAR.
Summary generated from market data by MetaCap's automated system. Methodology
What does Alpha Tau Medical do?
Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer. Its Alpha-DaRT technology is in clinical trials for various forms comprising skin, oral, pancreatic, prostate, lung, liver, and breast cancers; and preclinical clinical studies for mouse tumors and human-derived tumors. The company has a strategic collaboration agreement to develop and commercialize Alpha DaRT for the treatment of prostate cancer. The company is headquartered in Jerusalem, Israel.
Business description based on the company's public filings.
Company information
- Legal name
- Alpha Tau Medical Ltd.
- Ticker
- NASDAQ: DRTS
- Sector
- Health Care
- Industry
- Medical/Dental Instruments
- CEO
- Mr. Uzi Sofer
- Employees
- 121
- Headquarters
- Kiryat HaMada St. 5, Jerusalem, Israel
- Phone
- 972 3 577 4115
- Website
- alphatau.com
- Market cap
- $1.09B
- SEC CIK
- 0001871321
Companies similar to Alpha Tau Medical
| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| SIBNSI-BONE Inc. | 23.73 | -0.08% | $1.07B | vs DRTS |
| IRMDiRadimed Corporation | 81.02 | -0.30% | $1.04B | vs DRTS |
| IARTIntegra LifeSciences Holdings Corporation | 13.25 | -2.21% | $1.03B | vs DRTS |
| ATECAlphatec Holdings Inc. | 6.68 | -3.19% | $1.02B | vs DRTS |
| SGPSpyGlass Pharma Inc. | 30.43 | -1.14% | $1.02B | vs DRTS |
| TNDMTandem Diabetes Care Inc. | 17.46 | +3.93% | $1.22B | vs DRTS |
| NVCRNovoCure Limited | 10.71 | +0.19% | $1.25B | vs DRTS |
| AORTArtivion Inc. | 18.16 | -2.00% | $886.02M | vs DRTS |